Patents by Inventor Aaron D. Laposky

Aaron D. Laposky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GLP-1 RECEPTOR AGONIST COMPOUNDS FOR SLEEP ENHANCEMENT
    Publication number: 20120231022
    Abstract: The disclosure provides, among other things, the use of GLP-1 receptor agonist compounds to enhance sleep, increase the duration and/or intensity of non-rapid eye movement (NREM) sleep, treat NREM sleep disorders, and to treat circadian rhythm sleep disorders. The GLP-1 receptor agonist compounds may be exendins, exendin analogs, GLP-1(7-37), GLP-1(7-37) analogs (e.g., GLP-1(7-36)-NH2) and the like. In one embodiment, the GLP-1 receptor agonist compound is exenatide.
    Type: Application
    Filed: May 27, 2010
    Publication date: September 13, 2012
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Joseph T. Bass, Aaron D. Laposky, Fred W. Turek